CAS: 5331-14-6; (2-Butoxyethyl)Benzene

该化合物是其乙醚功能组的有机化合物,由附于2-丁氧乙基组的苯环组成,该化合物一般是无色的,可粉黄,具有典型芳香味,在水中可中溶性,在有机溶剂中更易溶,反映其非生物性质; 存在疏水(苯)和水(丁氧乙基)成分,允许其在各种应用中作为表面活性剂. (2-丁氧乙基)苯主要用作工业工艺的溶剂,特别是在油漆稀薄剂,涂层和清洁剂中,其化学稳定性和相对低的挥发性使其适合用于需要长期有效的制剂中.然而,与许多有机溶剂一样,由于潜在的健康影响,包括接触时的皮肤和呼吸刺激,应当谨慎处理,建议采取适当的安全措施,包括适当的通风和个人防护设备.

结构式图片

相似化合物

3558-60-9 103-52-6 56011-02-0

上下游产品

1-iodo-butane 2-phenylethanol 1-bromo-butane iodobenzene

合成工艺路线路线简述

  • 合成目标产物 Cressanther 主要起始原料 Phenylacetaldehyde And Butyraldehyde
  • (文献来源)合成步骤主要原料 Phenylacetaldehyde 和 Butyraldehyde
📜丁酸苯乙酯置于三乙基硅烷,Indium(Iii) Bromide体系中,用 氯仿 作为反应溶剂,以47 %的收率获得产物(2-丁氧乙基)苯
参考文献:半稳定 Nhc-金络合物及其在原料烯烃氧化还原中性 1,2-氧芳基化中的应用
标题:半稳定 Nhc-金络合物及其在原料烯烃氧化还原中性 1,2-氧芳基化中的应用
摘要:半不稳定 (C^n) N-杂环卡宾配体介导芳基碘化物与 Au I中心的氧化加成.对氧化加成过程进行了研究和计算分析.该过程实现了"无外源氧化剂"au I /au Iii催化乙烯和丙烯 1,2-氧基芳基化的第一个例子.
DOI:10.1002/anie.202301526

海关参考信息

专利信息


专利号:US-2005214310-A1
优先权日:2004-01-23
标 题 :Melphalan prodrugs
发明人:TOKI BRIAN E; SENTER PETER D
权利人:SEATTLE GENETICS INC
摘要:Shown and described are the synthesis of more potent forms of C-Mel, a prodrug used in Antibody-Directed Enzyme Prodrug Therapy, that releases the clinically used anticancer alkylating agent melphalan extracellularly. Shown and described are the synthesis of a variety of melphalan analogues with the intention to promote facile intracellular drug access. Esters, amides, and peptides of melphalan are shown. Cephalosporin prodrugs of the most interesting melphalan derivatives were synthesized and evaluated for potency, toxicity, therapeutic window, plasma stability, and solubility.

专利号:US-2008200475-A1
优先权日:2005-03-28
标题:4-Piperazinothieno[2,3-D] Pyrimidine Compounds As Platelet Aggregation Inhibitors
发明人:ENNIS MICHAEL DALTON; KORTUM STEVEN WADE; TENBRINK RUTH ELIZABETH
权利人:PFIZER
摘要:Compounds and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula I: (I) wherein A 1 , A 2 , A 3 , A 4 , A 5 , A 6 , A 7 , A 8 , X 4 , X 6 , R 2a , R x , R 4 , R 5 , and R 6 are as defined in the detailed description of the invention. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式

合成参考文献

合成方法参考DOI号:10.1021/acs.orglett.2c00270
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知